Nontuberculous Mycobacterium (NTM) species are increasingly recognized as opportunistic pathogens in companion animals, yet data on species distribution and antimicrobial resistance remain limited. The goal of this study was to evaluate species identification methods and determine antimicrobial susceptibility profiles of NTM isolates from cats and dogs submitted to the University of Tennessee veterinary diagnostic laboratory. Twenty-nine NTM isolates (25 feline, 4 canine) collected between 2016 and 2022 were cultured and identified using MALDI-TOF MS and 16S rRNA sequencing. Antimicrobial susceptibility testing (AST) was performed by broth microdilution. Most isolates (27/29) were rapidly growing mycobacteria from skin or wound samples. Combined MALDI-TOF and sequencing identified 11 isolates within the Mycobacterium fortuitum complex, 10 as M. smegmatis, 4 within the M. abscessus group, and one each as M. mucogenicum and M. farcinogenes. MALDI-TOF failed to identify four isolates, including two slow-growing strains. AST revealed consistent susceptibility to amikacin and moxifloxacin, while resistance was highest to doxycycline (44%), clarithromycin (37%), and tobramycin (33%). Rapidly growing NTM predominates in feline cutaneous infections, with species-specific resistance patterns underscoring the need for accurate identification and AST to guide therapy.